Vitamin A Drug May Reduce The Risk Of Breast Cancer

They found that the drug Fenretinide reduced second cancers in pre-menopausal women by 38 percent and halved the risk in those under 40. However, the cancer rate actually increased among post-menopausal women taking the drug, it said.

Fenretinide is a synthetic version of Retinol or active vitamin A, which can combat certain types of tumour.

However, Sarah Rawlings from Breakthrough Breast Cancer said: "Significantly more research is needed before any conclusions can be drawn."

"The researchers themselves say they are not yet in a position to make any clinical recommendations."

She warned that high doses of vitamin A could be harmful to unborn babies and cause other health problems.

--Edited IANS